http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101391020-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
filingDate | 2006-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101391020-B1 |
titleOfInvention | A pharmaceutical composition containing a water-soluble drug |
abstract | The present invention provides a pharmaceutical composition for solubilizing or dispersing a water-insoluble drug in a pharmaceutically acceptable liquid medium (e.g., an oil-in-water emulsion). The pharmaceutical composition is characterized by comprising (i) a base (e.g., polyethylene glycol), (ii) a poorly soluble drug, and (iii) a fatty acid or a pharmaceutically acceptable salt. For example, in the preparation of a pharmaceutical preparation for administration, such as an injection, by mixing with a pharmaceutically acceptable liquid medium, the pharmaceutical composition can be mixed in a short period of time and the poorly soluble drug can be homogeneously solubilized or dispersed in the liquid medium . |
priorityDate | 2005-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.